Joyzyme Group Limited (HKG:8622)
0.1760
-0.0020 (-1.12%)
Oct 7, 2026, 3:15 PM HKT
Joyzyme Group Revenue
Joyzyme Group had revenue of 16.56M CNY in the half year ending June 30, 2026, with 38.92% growth. This brings the company's revenue in the last twelve months to 32.51M, up 26.15% year-over-year. In the year 2025, Joyzyme Group had annual revenue of 28.28M with 11.53% growth. That makes Joyzyme Group the world's 40,083rd largest company by revenue and 2,459th in Hong Kong.
Revenue (ttm)
32.51M CNY
Revenue Growth
+26.15%
P/S Ratio
2.42
Revenue / Employee
331.73K CNY
Employees
98
Market Cap
90.72M HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.28M | 2.92M | 11.53% |
| Dec 31, 2024 | 25.36M | 730.00K | 2.96% |
| Dec 31, 2023 | 24.63M | -701.00K | -2.77% |
| Dec 31, 2022 | 25.33M | -797.00K | -3.05% |
| Dec 31, 2021 | 26.13M | 4.16M | 18.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.90B |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.05B |
| Kontafarma China Holdings | 845.33M |
| Wai Yuen Tong Medicine Holdings | 683.44M |
| Qianhai Health Holdings | 453.03M |
| Tianda Pharmaceuticals | 350.53M |
| PuraPharm Corporation | 323.49M |
| Fusen Pharmaceutical Company | 318.79M |